title: Serum alpha-fetoprotein levels predict early virologic response in HIV-positive subjects treated for chronic hepatitis C.
authors.forename: Marco
authors.initials: M
authors.lastname: Bongiovanni
authors.forename: Roberto
authors.initials: R
authors.lastname: Ranieri
authors.forename: Camilla
authors.initials: C
authors.lastname: Tincati
authors.forename: Maddalena
authors.initials: M
authors.lastname: Casana
authors.forename: Giulia
authors.initials: G
authors.lastname: Marchetti
authors.forename: Antonella d' Arminio
authors.initials: Ad
authors.lastname: Monforte
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000032:analysis; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011994:Recombinant Proteins; D019562:Viral Load; D000509:alpha-Fetoproteins / Q000032:analysis*
chemical_list: D015415:Biomarkers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D000509:alpha-Fetoproteins